Tricia Truehart

Tricia Truehart

Health Technology
Health Services
Finance

Profile

Tricia Truehart, formerly Head-Investor Relations & Communications at REGENXBIO, Inc. from 2019 to 2022, Principal at Beth Israel Deaconess Medical Center, Inc., Senior Associate at Trout Capital LLC from 2009 to 2018, Head-Investor Relations at Sio Gene Therapies, Inc. from 2018 to 2019, and Head-Investor Relations at GeneDx Holdings Corp.
in 2023.

Former positions of Tricia Truehart

CompaniesPositionEnd
GENEDX HOLDINGS CORP. Investor Relations Contact 2023-09-30
REGENXBIO INC. Investor Relations Contact 2022-02-28
SIO GENE THERAPIES INC. Investor Relations Contact 2019-07-31
Analyst-Equity 2018-05-31
Corporate Officer/Principal -
See the detail of Tricia Truehart's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tricia Truehart's experience

Connections

56

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
REGENXBIO INC.

Health Technology

GENEDX HOLDINGS CORP.

Health Services

Private companies3

Finance

Health Services

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Tricia Truehart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW